Correlation Between Gilead Sciences and Lexeo Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Lexeo Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Lexeo Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Lexeo Therapeutics, Common, you can compare the effects of market volatilities on Gilead Sciences and Lexeo Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Lexeo Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Lexeo Therapeutics,.

Diversification Opportunities for Gilead Sciences and Lexeo Therapeutics,

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Gilead and Lexeo is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Lexeo Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexeo Therapeutics, and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Lexeo Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexeo Therapeutics, has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Lexeo Therapeutics, go up and down completely randomly.

Pair Corralation between Gilead Sciences and Lexeo Therapeutics,

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.25 times more return on investment than Lexeo Therapeutics,. However, Gilead Sciences is 3.93 times less risky than Lexeo Therapeutics,. It trades about 0.04 of its potential returns per unit of risk. Lexeo Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest  7,829  in Gilead Sciences on November 9, 2024 and sell it today you would earn a total of  1,975  from holding Gilead Sciences or generate 25.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy64.1%
ValuesDaily Returns

Gilead Sciences  vs.  Lexeo Therapeutics, Common

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound essential indicators, Gilead Sciences is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Lexeo Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lexeo Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Gilead Sciences and Lexeo Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Lexeo Therapeutics,

The main advantage of trading using opposite Gilead Sciences and Lexeo Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Lexeo Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexeo Therapeutics, will offset losses from the drop in Lexeo Therapeutics,'s long position.
The idea behind Gilead Sciences and Lexeo Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets